Gene · 2213
Papers4,232
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 4,232
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Contradictory expression levels of FcγRIIB (CD32) on atypical-B cell populations in systemic sclerosis reflect immune system dysregulation. | Clin Immunol | 2025 | 40294834 | PubTator, text mining | PubMed |
| Fgl2 regulates FcγRIIB+CD8+ T cell responses during infection. | JCI Insight | 2025 | 40197366 | PubTator, text mining | PubMed |
| High FCGR2B Expression Can Identify Low-tumor-burden Follicular Lymphoma Patients Who Do Not Require Any Antilymphoma Therapy for a Long Term. | Am J Surg Pathol | 2025 | 40191878 | PubTator, text mining | PubMed |
| Drug survival of omalizumab in atopic asthma: Impact of clinical and genetic variables. | Hum Vaccin Immunother | 2025 | 40189906 | PubTator, text mining | PubMed |
| Macrophage-derived Fgl2 dampens antitumor immunity through regulation of FcγRIIB+CD8+ T cells in melanoma. | JCI Insight | 2025 | 40125553 | PubTator, text mining | PubMed |
Fibrinogen-like 2 in tumor-associated macrophage-derived extracellular vesicles shapes an immunosuppressive microenvironment in colorectal liver metastases by promoting tumor stemness and neutrophil extracellular traps formation. | Cancer Lett | 2025 | 40097065 | PubTator, text mining | PubMed |
| Identification and Characterization of the Structure and Size of Aβ42 Oligomers Targeting the Receptor FcγRIIb. | ACS Chem Neurosci | 2025 | 40094208 | PubTator, text mining | PubMed |
| Potential drug targets for ovarian cancer identified through Mendelian randomization and colocalization analysis. | J Ovarian Res | 2025 | 39972314 | PubTator, text mining | PubMed |
| Syk inhibitor attenuates lupus in FcγRIIb-/- mice through the Inhibition of DNA extracellular traps from macrophages and neutrophils via p38MAPK-dependent pathway. | Cell Death Discov | 2025 | 39962056 | PubTator, text mining | PubMed |
| Potential drug targets for systemic lupus erythematosus identified through Mendelian randomization analysis. | Medicine (Baltimore) | 2025 | 39960916 | PubTator, text mining | PubMed |
| Bioinformatics Analysis of Programmed Death-1-Trastuzumab Resistance Regulatory Networks in Breast Cancer Cells. | Asian Pac J Cancer Prev | 2025 | 39874011 | PubTator, text mining | PubMed |
| With great power, comes great responsibility: the importance of broadly measuring Fc-mediated effector function early in the antibody development process. | MAbs | 2025 | 39819511 | PubTator, text mining | PubMed |
| Protein-Based Degraders: From Chemical Biology Tools to Neo-Therapeutics. | Chem Rev | 2025 | 39818743 | PubTator, text mining | PubMed |
| Interaction study of the effects of environmental exposure and gene polymorphisms of inflammatory and immune-active factors on chronic obstructive pulmonary disease. | Respir Res | 2025 | 39780163 | PubTator, text mining | PubMed |
| Underappreciated layers of antibody-mediated immune synapse architecture and dynamics. | mBio | 2025 | 39660921 | PubTator, text mining | PubMed |
| Pharmacokinetics, Pharmacodynamics, Bioavailability, and Immunogenicity of Obexelimab Following Subcutaneous Administration in Healthy Japanese and Non-Japanese Volunteers. | Adv Ther | 2025 | 39636565 | PubTator, text mining | PubMed |
| An Expression Quantitative Trait Locus of Fc Gamma Receptor Genes Is Associated With Antimalarial IgG Responses and Infection Levels in Burkinabe Families. | J Infect Dis | 2025 | 39450553 | PubTator, text mining | PubMed |
| Circulating B cells display differential immune regulatory molecule expression in granulomatosis with polyangiitis. | Clin Exp Immunol | 2025 | 39435875 | PubTator, text mining | PubMed |
| Machine learning-based identification and validation of immune-related biomarkers for early diagnosis and targeted therapy in diabetic retinopathy. | Gene | 2025 | 39427825 | PubTator, text mining | PubMed |
| On the role of antibody affinity and avidity in the IgE-mediated allergic response. | Allergy | 2025 | 39189064 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2213/papers?page=8